For: |
Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, Yakovenko EP, Gulyaev PV, Fedchenko VI. Azithromycin in a triple therapy for |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i5/879.htm |
Number | Citing Articles |
1 |
Ignasi Puig, Mireia Baylina, Jordi Sánchez-Delgado, Sheila López-Gongora, David Suarez, Pilar García-Iglesias, Neus Muñoz, Javier P. Gisbert, Cristina Dacoll, Henry Cohen, Xavier Calvet. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment. Journal of Antimicrobial Chemotherapy 2016; 71(10): 2740 doi: 10.1093/jac/dkw220
|
2 |
Jie Dong, Xiao-Feng Yu, Jian Zou. Azithromycin-containing <italic>versus</italic> standard triple therapy for <italic>Helicobacter pylori</italic> eradication: A meta-analysis. World Journal of Gastroenterology 2009; 15(48): 6102-6110 doi: 10.3748/wjg.15.6102
|
3 |
Yang Bai, Ying-Chun Dai, Jian-Dong Li, Jun Nie, Qing Chen, Hong Wang, Yong-Yu Rui, Ya-Li Zhang, Shou-Yi Yu. Acute diarrhea during army field exercise in southern China. World Journal of Gastroenterology 2004; 10(1): 127-131 doi: 10.3748/wjg.v10.i1.127
|
4 |
M. Escobedo-Belloc, F. Bosques-Padilla. The rise of antibiotic resistance to Helicobacter pylori in Mexico: Is azithromycin plus levofloxacin the answer?. Revista de Gastroenterología de México (English Edition) 2019; 84(3): 271 doi: 10.1016/j.rgmxen.2018.10.006
|
5 |
Laura Cidrão Frota, Maria do Perpétuo Socorro Saldanha da Cunha, Carlos René Lima Luz, Antonio Haroldo de Araujo-Filho, Luciano A. S. Frota, Lucia Libanez Bessa Campelo Braga. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. Arquivos de Gastroenterologia 2005; 42(2): 111 doi: 10.1590/S0004-28032005000200009
|
6 |
Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology. 2010; : 102 doi: 10.1002/9781444314403.ch6
|
7 |
Asma Nizam, Zao Iman Chaudary, Saad Ali Ahmad, Nimra Nawaz, Zainab Riaz, Aamir Shehzad, Muhammad Irfan Jamil. Comparison of the Efficacy of Two-Week Vonoprazan Versus Lansoprazole-Based Quadruple Sequential Antibiotic Therapy in Eradicating Helicobacter pylori Infection: A Non-randomized Clinical Trial. Cureus 2024; doi: 10.7759/cureus.52758
|
8 |
Naoki Chiba. Evidence‐based Gastroenterology and Hepatology. 2004; : 83 doi: 10.1002/9780470987025.ch5
|
9 |
Jae Yeon Kim, Nayoung Kim, Sung Jung Kim, Gwang Ho Baik, Gwang Ha Kim, Jung Mogg Kim, Ryoung Hee Nam, Hong Bin Kim, Dong Ho Lee, Hyun Chae Jung, In Sung Song. Regional Difference of Antibiotic Resistance ofHelicobacter pyloriStrains in Korea. The Korean Journal of Gastroenterology 2011; 57(4): 221 doi: 10.4166/kjg.2011.57.4.221
|
10 |
Jung Mogg Kim, Joo Sung Kim, Nayoung Kim, Sang Gyun Kim, Hyun Chae Jung, In Sung Song. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. International Journal of Antimicrobial Agents 2006; 28(1): 6 doi: 10.1016/j.ijantimicag.2006.02.015
|
11 |
Shahram Agah, Babak Shazad, Babak Abbaszadeh. Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. Saudi Journal of Gastroenterology 2009; 15(4): 225 doi: 10.4103/1319-3767.56091
|
12 |
Jae Yeon Kim, Nayoung Kim, Hyun Kyung Park, Hyun Jin Jo, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Ryoung Hee Nam, Jung Mogg Kim, Ji Hyun Lee, Hyun Chae Jung, In Sung Song. Primary Antibiotic Resistance ofHelicobacter pyloriStrains and Eradication Rate according to Gastroduodenal Disease in Korea. The Korean Journal of Gastroenterology 2011; 58(2): 74 doi: 10.4166/kjg.2011.58.2.74
|
13 |
Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung, Nayoung Kim, Young-Jeon Kim, In Sung Song.
Distribution of Antibiotic MICs for
Helicobacter pylori
Strains over a 16-Year Period in Patients from Seoul, South Korea
. Antimicrobial Agents and Chemotherapy 2004; 48(12): 4843 doi: 10.1128/AAC.48.12.4843-4847.2004
|
14 |
Shahrokh Mousavi, Jafar Toussy, Siamak Yaghmaie, Mehrdad Zahmatkesh. Azithromycin in one week quadruple therapy for <italic>H pylori</italic> eradication in Iran. World Journal of Gastroenterology 2006; 12(28): 4553-4556 doi: 10.3748/wjg.v12.i28.4553
|
15 |
Chuan-Yong Guo, Yun-Bin Wu, Heng-Lu Liu, Jian-Ye Wu, Min-Zhang Zhong. Clinical evaluation of four one-week triple therapy regimens in eradicating <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2004; 10(5): 747-749 doi: 10.3748/wjg.v10.i5.747
|
16 |
M. Escobedo-Belloc, F. Bosques-Padilla. El incremento en la resistencia de Helicobacter pylori a los antibióticos en México: ¿son la azitromicina más levofloxacina la respuesta?. Revista de Gastroenterología de México 2019; 84(3): 271 doi: 10.1016/j.rgmx.2018.10.005
|